MoneyWorks4Me

Syncom Formulations (India) submits reconciliation of share capital audit report

13 Jan 2023 Evaluate
With reference to the compliance of Regulation 76 of SEBI (Depositories and Participants) Regulations, 2018 (Previously known as Regulations 55A of SEBI (Depositories and Participants) Regulations 1996} & Circular No. D&CC/FITTC/CIR-16/2002 dated December 31st 2002 issued by SEBI, Syncom Formulations (India) has submitted Reconciliation of Share Capital Audit Report for the Quarter ended 31st December, 2022. The Reconciliation of Share Capital Audit Report will also be filed in XBRL mode within the stipulated time period.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..